ArKal Medical, Inc.

ArKal Medical, Inc.

ArKal Medical, Inc.

Date Founded



46575 Fremont Boulevard,Fremont, CA 94538

Type of Company



Medical Products & Equipment
Hospitals & Patient Services
Holding Companies

Company Description

ArKal Medical, Inc. develops blood glucose sensors for patients with diabetes. The firm provides painless access to ISF glucose and developing a next generation continuous glucose monitoring system for the management of diabetes. It is monitoring system is designed to reduce many of the inconveniences of current continuous glucose monitoring systems. The company was founded by Arvind Jina in 2005 and is headquartered in Fremont, CA.

Contact Data
Trying to get in touch with decision makers at ArKal Medical, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Paths to ArKal Medical, Inc.
Potential Connections via
Relationship Science
ArKal Medical, Inc.
Details Hidden

MedVenture Associates focuses on investments in the medical technology sector, including medical devices, eHealth, healthcare services, instrumentation and medical diagnostics. The firm also invests in medical information technology, pharmaceuticals and biotechnology products. MedVenture Associates specializes in pre-seed, seed and early-stage investments. They also consider later-stage opportunities in which early investment liquidity is expected. The firm prefers to invest in early-stage companies located in the Western region of the continental US. MedVentures Associates invests in later-stage companies without regard to location. The firm seeks to serve as a sole or lead founding investor and they typically take a seat on their portfolio companies' boards of directors.

Details Hidden

Thomas, McNerney & Partners (TMP) invests in life science and medical technology companies at all stages of development. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. They are particularly interested in companies that are developing therapeutic products for life threatening or costly, chronic health conditions.TMP may invest in start-up companies, provide growth capital to emerging companies and participate in restructuring transactions including spin-outs, roll-ups and recapitalizations.TMP typically invests $5 million to $40 million in one or more rounds of financing, with an average investment of more than $15 million over the life of an investment. Initial investments may be as small as $100,000. The firm prefers to lead the financing round in which they first participate.TMP looks for companies with a focus on large, rapidly growing and underserved market segments that are ready to undergo change. Companies should be able to achieve a leadership position or have already established one in targeted market segments. They should have a convincing business model with the potential to achieve significant, sustainable value with reasonable risk. TMP also seeks companies with strong leadership, reasonable regulatory timelines with well-defined endpoints, technology development that integrates existing technologies in new ways, a case for acceptable product reimbursement and a solid intellectual property position.

Details Hidden

Shellwater & Co. is an American private company. The firm provides investment services.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ArKal Medical, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ArKal Medical, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ArKal Medical, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15